Cefoperazone Sodium
- CEFOPERAZONE SODIUM
- 62893-20-3
- Cefoperazone sodium salt
- Sodium cefoperazone
- Cefobid
- Create:2008-02-05
- Modify:2025-01-18
- Céfobis
- Cefobid
- Cefoperazon
- Cefoperazone
- Cefoperazone Sodium
- Cefoperazone Sodium Salt
- Salt, Cefoperazone Sodium
- Sodium Salt, Cefoperazone
- Sodium, Cefoperazone
- T 1551
- T-1551
- T1551
- CEFOPERAZONE SODIUM
- 62893-20-3
- Cefoperazone sodium salt
- Sodium cefoperazone
- Cefobid
- Tomabef
- T-1551
- CP 52640-2
- Cefoperazone (as sodium)
- CEFOBID IN PLASTIC CONTAINER
- EINECS 263-751-5
- UNII-5FQG9774WD
- Cefobis
- 5FQG9774WD
- DTXSID6045874
- Cefoperazone (sodium salt)
- CP-52,640-2
- NSC-758173
- CP-526402
- CHEBI:3494
- CP-52640-2
- DTXCID4025874
- Cefoperazone sodium [USAN:USP:JAN]
- NSC 758173
- 62893-20-3 (SODIUM)
- Cefobid (TN)
- SULPERAZONE COMPONENT CEFOPERAZONE SODIUM
- sodium;(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- CEFOPERAZONE SODIUM (MART.)
- CEFOPERAZONE SODIUM [MART.]
- Cefoperazone sodium (USAN:USP:JAN)
- MFCD07793331
- 1094606-34-4
- CEFOPERAZONE SODIUM (EP IMPURITY)
- CEFOPERAZONE SODIUM [EP IMPURITY]
- CEFOPERAZONE SODIUM (EP MONOGRAPH)
- CEFOPERAZONE SODIUM [EP MONOGRAPH]
- CEFOPERAZONE SODIUM (USP MONOGRAPH)
- CEFOPERAZONE SODIUM [USP MONOGRAPH]
- CAS-62893-20-3
- Sodium, Cefoperazone
- Salt, Cefoperazone Sodium
- Sodium Salt, Cefoperazone
- T 1551
- Cefoperazin
- Cefoneg
- Cefoper
- cefoperazon-natrium
- NCGC00094952-01
- cefobid sodium salt
- cefoperazone, sodium salt
- Sodium (6R,7R)-7-((R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- SCHEMBL537680
- HY-B0210AR
- CHEMBL1200482
- HY-B0210A
- CEFOPERAZONE SODIUM [JAN]
- Cefoperazone sodium (JP18/USP)
- NCFTXMQPRQZFMZ-WERGMSTESA-M
- CEFOPERAZONE SODIUM [USAN]
- CEFOPERAZONE SODIUM [VANDF]
- Tox21_111367
- CEFOPERAZONE SODIUM [WHO-DD]
- CEFOPERAZONE SODIUM SALT [MI]
- AKOS015951266
- Cefoperazone (sodium salt) (Standard)
- Tox21_111367_1
- CCG-270350
- CS-5023
- CEFOPERAZONE SODIUM [ORANGE BOOK]
- NCGC00179599-03
- 1ST12007
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(R*)))-
- C08112
- D00918
- CEFOPERAZONE SODIUM COMPONENT OF SULPERAZONE
- Q27106107
- Cefoperazone sodium 100 microg/mL in Acetonitrile/Water
- (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- SODIUM (6R,7R)-7-((R)-2-(4-ETHYL-2,3-DIOXO-1-PIPERAZINECARBOXAMIDO)-2-(P-HYDROXYPHENYL)ACETAMIDO-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLATE
- Sodium (6R,7R)-7-((R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-7-((R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium(6R,7R)-7-((R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
H317 (98.1%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H334 (96.2%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 53 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Skin Sens. 1 (98.1%)
Resp. Sens. 1 (96.2%)
◉ Summary of Use during Lactation
Cefoperazone is no longer marketed in the United States. Limited information indicates cefoperazone produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with cephalosporins, but these effects have not been adequately evaluated. Cefoperazone is acceptable in nursing mothers.
◉ Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
◉ Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=NCFTXMQPRQZFMZ-WERGMSTESA-M
- Australian Industrial Chemicals Introduction Scheme (AICIS)5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6.alpha.,7.beta.(R*)]]-https://services.industrialchemicals.gov.au/search-inventory/
- ChemIDplusCefoperazone sodium [USAN:USP:JAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0062893203ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- EPA DSSToxCefoperazone sodiumhttps://comptox.epa.gov/dashboard/DTXSID6045874CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-notice5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6α,7β(R*)]]-https://echa.europa.eu/substance-information/-/substanceinfo/100.057.9375-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6α,7β(R*)]]- (EC: 263-751-5)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/24166
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingCEFOPERAZONE SODIUMhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/5FQG9774WD
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- ChEBICefoperazone sodiumhttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3494
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licenceCEFOPERAZONE SODIUMhttps://platform.opentargets.org/drug/CHEMBL1200482
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jsp
- Drugs and Lactation Database (LactMed)
- Drugs@FDALICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- FDA Orange BookLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.kegAntiinfectiveshttp://www.genome.jp/kegg-bin/get_htext?br08307.kegDrugs listed in the Japanese Pharmacopoeiahttp://www.genome.jp/kegg-bin/get_htext?br08311.keg
- Metabolomics WorkbenchCEFOPERAZONE SODIUMhttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=71065
- Springer Nature
- Wikidatacefoperazone sodiumhttps://www.wikidata.org/wiki/Q27106107
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlCefoperazonehttps://www.ncbi.nlm.nih.gov/mesh/68002438Anti-Bacterial Agentshttps://www.ncbi.nlm.nih.gov/mesh/68000900
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/NORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 396251702https://pubchem.ncbi.nlm.nih.gov/substance/396251702